De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review - Guo Hanxu; Jin Chengqi; Ding Li; Xie Jun; Xu Jing; Wang Ruiliang; Wang Hong; Guo Changcheng; Zhang Jiansheng; Peng Bo; Yao Xudong; Yuan Jing; et al. (中华医学杂志英文版, 2025)